Clinical trial Recruiting at 1 site Interventional Ages 14 to 18

A human-values program to help teens prevent and cope with cyberbullying

Official title: The Effect on Adolescents' Cyberbullying/Cyber Victimization and Coping Skills of the Human Values-Oriented Cyberbullying Prevention Program

Run by University of Gaziantep · NCT07443748 · Data updated 2026-11-12

This project will test whether a human-values program can reduce cyberbullying and help teens aged 14–18 cope better after online bullying.

Quick facts

Study typeInterventional
Ages14 Years to 18 Years
SexAll
Enrollment80 (estimated)
SponsorUniversity of Gaziantep
Academic / other
Locations2 sites (Adana, Çukurova and 1 other locations)
StatusRecruiting
StartedFebruary 13, 2026
Main results expectedMay 2026
Study endsJune 2026
Registry record updatedMarch 2, 2026
Trial IDNCT07443748 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are volunteers aged 14–18 who live in Adana city center, can communicate in person, have active internet access, and score 23 or higher on the Cyber Victimization and Bullying Scale.

Probably not a fit

Teens who have not experienced cyberbullying, lack active internet access, cannot attend in-person sessions, or fall outside the 14–18 age range are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will enroll adolescents who report past cyberbullying and divide them into an experimental group that receives the human values–oriented prevention program and a control group that does not. Data will be collected with face-to-face interviews and standardized pre-tests including a Personal Information Form, the Cyber Victimization and Bullying Scale, and the Coping Scale for Adolescents. Outcomes will compare changes in reported cyberbullying/cybervictimization and coping skills between groups. The intervention is delivered in school settings at participating high schools in Adana.

Why it matters

Potential benefit: If successful, the program could lower cyberbullying incidents and improve coping skills among participating adolescents.

How similar studies have gone: School-based and values- or skills-oriented anti-bullying programs have shown mixed but often promising results for reducing bullying and improving coping, while this exact human-values program is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Volunteering to participate in the study
* Residing in the city center of Adana
* Not having any condition that prevents communication
* Being between 14 and 18 years of age
* Having experienced cyberbullying or cyber victimization (those who score 23 points or higher on the scale will be included in the study.)

Exclusion Criteria:

* Not having experienced cyberbullying or cybervictimization according to the findings of the Cyber Victimization and Bullying Scale
* Not having active internet access

Where it's running

  • Şehit Mustafa Görenoğlu Anadolu Lisesi
    Adana, Çukurova, Turkey (Türkiye)
    Recruiting
  • Hasan Adali Anadolu Lisesi
    Adana, Çukurova, Turkey (Türkiye)
    Not yet recruiting

Study contacts

  • Principal investigator: PELİN BÜYÜKSANDIÇ ÖZŞEN, MSc,PhD Candidate — GAZİANTEP UNiVERSiTY
  • Study coordinator: PELİN BÜYÜKSANDIÇ ÖZŞEN, MSc, PhD Candidate
  • Email: pelinbuyuksandic@hotmail.com
  • Phone: +905448500111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.